ImmunoGen Pronounces Webcasts of Shows at Upcoming Conferences

WALTHAM, Mass., February 01, 2023–(BUSINESS WIRE)–ImmunoGen, Inc. (Nasdaq: IMGN), a frontrunner within the increasing subject of antibody-drug conjugates (ADCs) for the remedy of most cancers, in the present day introduced that the next displays by Firm administration at upcoming investor conferences will probably be webcast:

February 9 at 3:20pm ET

February 15 at 10:00am ET

A webcast of every presentation will probably be accessible by means of the “Traders and Media” part of the Firm’s web site, www.immunogen.com. Following the stay webcast, a replay will probably be accessible on the identical location.

ABOUT IMMUNOGEN

ImmunoGen is growing the subsequent era of antibody-drug conjugates (ADCs) to enhance outcomes for most cancers sufferers. By producing focused therapies with enhanced anti-tumor exercise and favorable tolerability profiles, we goal to disrupt the development of most cancers and supply our sufferers extra good days. We name this our dedication to TARGET A BETTER NOW™.

Study extra about who we’re, what we do, and the way we do it at www.immunogen.com.

View supply model on businesswire.com: https://www.businesswire.com/news/home/20230201005203/en/

Contacts

INVESTOR RELATIONS
ImmunoGen
Anabel Chan
781-895-0600
[email protected]

MEDIA
ImmunoGen
Courtney O’Konek
781-895-0600
[email protected]

OR

FTI Consulting
Robert Stanislaro
212-850-5657
[email protected]